nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant Therapy of Renal Cell Carcinoma
|
Yap, Timothy A. |
|
2006 |
5 |
2 |
p. 120-130 11 p. |
artikel |
2 |
A Phase II Study of Weekly Paclitaxel/Estramustine/Carboplatin in Hormone-Refractory Prostate Cancer
|
Berry, William |
|
2006 |
5 |
2 |
p. 131-137 7 p. |
artikel |
3 |
Assessing Progress Against Prostate Cancer
|
Sartor, Oliver |
|
2006 |
5 |
2 |
p. 102-103 2 p. |
artikel |
4 |
Current Data with Mammalian Target of Rapamycin Inhibitors in Advanced Renal Cell Carcinoma
|
Reddy, G. Kesava |
|
2006 |
5 |
2 |
p. 110-113 4 p. |
artikel |
5 |
Highlights from: The Third International Congress on Kidney and Bladder Cancer; Orlando, FL; August 3-6, 2006
|
Reddy, G. Kesava |
|
2006 |
5 |
2 |
p. 104-109 6 p. |
artikel |
6 |
Interleukin-2 Therapy of Metastatic Renal Cell Carcinoma: Update of Phase III Trials
|
McDermott, David F. |
|
2006 |
5 |
2 |
p. 114-119 6 p. |
artikel |
7 |
Intermittent Hormone Therapy in Nonmetastatic Prostate Cancer
|
Opfermann, Krisha J. |
|
2006 |
5 |
2 |
p. 138-143 6 p. |
artikel |
8 |
Phase II Trial of Adjuvant Gemcitabine plus Cisplatin-Based Chemotherapy in Patients with Locally Advanced Bladder Cancer
|
Jin, James O. |
|
2006 |
5 |
2 |
p. 150-154 5 p. |
artikel |
9 |
Phase II Trial of Docetaxel/Capecitabine in Hormone-Refractory Prostate Cancer
|
Kolodziej, Michael |
|
2006 |
5 |
2 |
p. 155-161 7 p. |
artikel |
10 |
Selected Clinical Trials in Renal Cell Carcinoma
|
|
|
2006 |
5 |
2 |
p. 171- 1 p. |
artikel |
11 |
Stromal-Epithelial Interaction in Prostate Cancer Progression
|
Chung, Leland W.K. |
|
2006 |
5 |
2 |
p. 162-170 9 p. |
artikel |
12 |
Thalidomide/Estramustine/Paclitaxel in Metastatic Androgen-Independent Prostate Cancer
|
Mathew, Paul |
|
2006 |
5 |
2 |
p. 144-149 6 p. |
artikel |